Berry Genomics Co Ltd Market Cap ($469.72 Million)
Market Cap & Net Worth: Berry Genomics Co Ltd (000710)
Berry Genomics Co Ltd market cap. Berry Genomics Co Ltd (SHE:000710) has a market capitalization of $469.72 Million (CN¥3.21 Billion) as of November 5, 2026. Listed on the SHE stock exchange, this China-based company holds position #12287 globally and #3529 in its home market, demonstrating a -1.30% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Berry Genomics Co Ltd's stock price CN¥9.08 by its total outstanding shares 353521465 (353.52 Million). Also see how efficiently does Berry Genomics Co Ltd generate cash for how efficiently the company converts equity into cash flow.
Berry Genomics Co Ltd Market Cap History (2015–2026)
Berry Genomics Co Ltd market cap history from 2015 to 2026. Data shows change from $2.11 Billion to $469.72 Million (-9.59% CAGR). Check 000710 stock price and chart for real-time trading data and today's change.
Berry Genomics Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Berry Genomics Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore 000710 shareholders equity momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.41x
Berry Genomics Co Ltd's market cap is 0.41 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $2.11 Billion | $230.06 Million | -$13.01 Million | 9.19x | N/A |
| 2016 | $2.45 Billion | $247.38 Million | -$4.19 Million | 9.91x | N/A |
| 2017 | $2.92 Billion | $1.17 Billion | $232.75 Million | 2.49x | 12.53x |
| 2018 | $1.65 Billion | $1.44 Billion | $268.09 Million | 1.15x | 6.16x |
| 2019 | $1.89 Billion | $1.62 Billion | $390.62 Million | 1.17x | 4.85x |
| 2020 | $1.97 Billion | $1.54 Billion | $210.67 Million | 1.28x | 9.35x |
| 2021 | $1.00 Billion | $1.42 Billion | -$109.86 Million | 0.71x | N/A |
| 2022 | $590.25 Million | $1.37 Billion | -$252.25 Million | 0.43x | N/A |
| 2023 | $595.94 Million | $1.15 Billion | -$427.20 Million | 0.52x | N/A |
| 2024 | $437.13 Million | $1.08 Billion | -$192.43 Million | 0.41x | N/A |
Competitor Companies of 000710 by Market Capitalization
Companies near Berry Genomics Co Ltd in the global market cap rankings as of November 5, 2026. Also see 000710 total assets for a full breakdown of the balance sheet.
Key companies related to Berry Genomics Co Ltd by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #86 globally with a market cap of $224.59 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #138 globally with a market cap of $165.94 Billion USD.
- Natera Inc (NASDAQ:NTRA): Ranked #479 globally with a market cap of $56.33 Billion USD.
- WuXi AppTec Co Ltd (SHG:603259): Ranked #505 globally with a market cap of $53.86 Billion USD ( CN¥368.05 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #86 | Thermo Fisher Scientific Inc | NYSE:TMO | $224.59 Billion | $706.16 |
| #138 | Danaher Corporation | NYSE:DHR | $165.94 Billion | $234.93 |
| #479 | Natera Inc | NASDAQ:NTRA | $56.33 Billion | $391.03 |
| #505 | WuXi AppTec Co Ltd | SHG:603259 | $53.86 Billion | CN¥148.81 |
Market Capitalization of Berry Genomics Co Ltd (2015–2026)
Market capitalization of Berry Genomics Co Ltd from 2015 to today. Between 2015 and today, Berry Genomics Co Ltd's market cap moved from $2.11 Billion to $ 469.72 Million, with a yearly change of -9.59%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥469.72 Million | -19.57% |
| 2025 | CN¥584.05 Million | +33.61% |
| 2024 | CN¥437.13 Million | -26.65% |
| 2023 | CN¥595.94 Million | +0.96% |
| 2022 | CN¥590.25 Million | -41.19% |
| 2021 | CN¥1.00 Billion | -49.03% |
| 2020 | CN¥1.97 Billion | +3.99% |
| 2019 | CN¥1.89 Billion | +14.73% |
| 2018 | CN¥1.65 Billion | -43.41% |
| 2017 | CN¥2.92 Billion | +18.90% |
| 2016 | CN¥2.45 Billion | +15.97% |
| 2015 | CN¥2.11 Billion | -- |
End of Day Market Cap According to Different Sources
On Nov 5th, 2026 the market cap of Berry Genomics Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $469.72 Million USD |
| MoneyControl | $469.72 Million USD |
| MarketWatch | $469.72 Million USD |
| marketcap.company | $469.72 Million USD |
| Reuters | $469.72 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Berry Genomics Co Ltd
Berry Genomics Co.,Ltd, a genomics and life science company, develops and commercializes of genetic test technologies in clinical applications in China. The company offers non-invasive DNA prenatal testing service, genetic disease testing, tumor genetic testing, NextSeq CN500 gene sequencer, and laboratory solutions. It also provides technology services, such as human genome sequencing, transcri… Read more